2017 | Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial. | LANCET HAEMATOLOGY |
2017 | Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study. | LEUKEMIA |
2017 | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
| ONCOTARGET |
2017 | Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
| ONCOTARGET |
2017 | Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma | HEMATOLOGICAL ONCOLOGY |
2017 | Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
| ONCOTARGET |
2017 | The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)
| ONCOTARGET |
2017 | Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
| BLOOD RESEARCH |
2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
2017 | Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort
| BLOOD RESEARCH |
2017 | Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
| BLOOD RESEARCH |
2017 | Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2017 | Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation
| RADIATION ONCOLOGY JOURNAL |
2017 | Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores | ANNALS OF HEMATOLOGY |
2017 | Hematopoietic stem cell mobilization: current status and future perspective
| BLOOD RESEARCH |
2017 | 내과 전문의 시험제도의 발전방향
| Korean Journal of Medicine |
2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| CELL TRANSPLANTATION |
2017 | Prognostic significance of interventricular septal thickness in patients with AL amyloidosis | LEUKEMIA RESEARCH |
2017 | AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells | CLINICAL CANCER RESEARCH |
2017 | Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
| YONSEI MEDICAL JOURNAL |
2017 | Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells. | AUTOPHAGY |
2017 | The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma | ANNALS OF HEMATOLOGY |
2016 | Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
| BMC CANCER |
2016 | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | LANCET ONCOLOGY |
2016 | Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia | ANNALS OF ONCOLOGY |
2016 | Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
| BLOOD RESEARCH |
2016 | A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas | ANNALS OF ONCOLOGY |
2016 | Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29) | QUALITY OF LIFE RESEARCH |
2016 | A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial | LEUKEMIA & LYMPHOMA |
2016 | Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen | ANNALS OF HEMATOLOGY |
2016 | Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study
| ANNALS OF HEMATOLOGY |
2016 | Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study
| ONCOTARGET |
2016 | The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma | BRITISH JOURNAL OF HAEMATOLOGY |
2016 | Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin | ANNALS OF ONCOLOGY |
2016 | Daratumumab 투여를 받은 다발성 골수종 환자에서 비예기항체 동정검사상 범응집 소견을 보인 1예
| Korean Journal of Blood Transfusion (대한수혈학회지) |
2016 | Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2016 | The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase | ANNALS OF HEMATOLOGY |
2016 | The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
| YONSEI MEDICAL JOURNAL |
2016 | Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF. | LEUKEMIA & LYMPHOMA |
2016 | Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2016 | Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study. | ANNALS OF HEMATOLOGY |
2016 | A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma | EUROPEAN JOURNAL OF CANCER |
2016 | Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2016 | High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma. | LEUKEMIA & LYMPHOMA |
2016 | Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry | ANNALS OF HEMATOLOGY |
2015 | Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome.
| ANTICANCER RESEARCH |
2015 | Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
| BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2015 | Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea.
| BLOOD RESEARCH |
2015 | Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma. | LEUKEMIA & LYMPHOMA |
2015 | Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study
| BLOOD RESEARCH |